Skip to main content
. Author manuscript; available in PMC: 2011 Feb 1.
Published in final edited form as: Int J Radiat Oncol Biol Phys. 2010 Feb 1;76(2):566. doi: 10.1016/j.ijrobp.2009.08.031

Table 1.

Summary of MLL aberrations

SAHA
Treatment
Total
aberrations
DNA
rearrangements
Translocation
(%)
Microhomology
(bp)
0.0 μM 14 4 28.57 4.5 ± 1.3
0.5 μM 12 5 41.67 4.6 ±2.1
2.0 μM 15 9 60.00 3.1 ± 0.8

All the three groups were treated with anti-CD95 antibody following pre-treatment with 0.0 μM (DMSO only), 0.5 μM and 2.0 μM SAHA respectively.